Hamilton Thorne Ltd. (HTLZF)
USD 1.59
(N/A%)
USD 1.59
(N/A%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 277.99 Thousand USD | -97.75% |
| 2022 | 12.58 Million USD | 229.84% |
| 2021 | 3.81 Million USD | 33.72% |
| 2020 | 2.85 Million USD | -11.5% |
| 2019 | 3.22 Million USD | -10.31% |
| 2018 | 3.59 Million USD | 48.34% |
| 2017 | 2.42 Million USD | 147.98% |
| 2016 | 977.47 Thousand USD | -23.41% |
| 2015 | 1.27 Million USD | 16.81% |
| 2014 | 1.09 Million USD | 215.87% |
| 2013 | 345.88 Thousand USD | 125.79% |
| 2012 | -1.34 Million USD | 2.15% |
| 2011 | -1.37 Million USD | 8.76% |
| 2010 | -1.5 Million USD | -14.78% |
| 2009 | -1.3 Million USD | -280.26% |
| 2008 | -344.13 Thousand USD | -57.1% |
| 2007 | -219.05 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -42.29 Thousand USD | -104.39% |
| 2024 Q2 | -32.76 Thousand USD | -398.8% |
| 2023 FY | 283.09 Thousand USD | -97.75% |
| 2023 Q2 | -342.17 Thousand USD | -178.28% |
| 2023 Q3 | -753.61 Thousand USD | -120.24% |
| 2023 Q4 | 962.53 Thousand USD | 227.72% |
| 2023 Q1 | 437.13 Thousand USD | -89.85% |
| 2022 Q4 | 4.3 Million USD | 2747.52% |
| 2022 Q3 | -162.64 Thousand USD | -128.24% |
| 2022 FY | 12.58 Million USD | 229.84% |
| 2022 Q1 | 960.89 Thousand USD | -25.24% |
| 2022 Q2 | 575.92 Thousand USD | -40.06% |
| 2021 Q2 | 795.35 Thousand USD | -37.32% |
| 2021 Q1 | 1.26 Million USD | -12.42% |
| 2021 Q4 | 1.28 Million USD | 175.39% |
| 2021 FY | 3.81 Million USD | 33.72% |
| 2021 Q3 | 466.72 Thousand USD | -41.32% |
| 2020 Q3 | 709.4 Thousand USD | 348.02% |
| 2020 FY | 2.85 Million USD | -11.5% |
| 2020 Q2 | -286.03 Thousand USD | -129.13% |
| 2020 Q4 | 1.44 Million USD | 104.23% |
| 2020 Q1 | 981.78 Thousand USD | 2.14% |
| 2019 Q4 | 961.26 Thousand USD | 49.71% |
| 2019 Q1 | 1.01 Million USD | 38.85% |
| 2019 FY | 3.22 Million USD | -10.31% |
| 2019 Q2 | 605.02 Thousand USD | -40.47% |
| 2019 Q3 | 642.07 Thousand USD | 6.12% |
| 2018 Q1 | 1.01 Million USD | 80.49% |
| 2018 FY | 3.59 Million USD | 48.34% |
| 2018 Q4 | 731.98 Thousand USD | -13.54% |
| 2018 Q3 | 846.57 Thousand USD | -15.51% |
| 2018 Q2 | 1 Million USD | -1.29% |
| 2017 Q2 | 446.92 Thousand USD | -8.78% |
| 2017 Q1 | 489.93 Thousand USD | -19.4% |
| 2017 FY | 2.42 Million USD | 147.98% |
| 2017 Q4 | 562.39 Thousand USD | -39.18% |
| 2017 Q3 | 924.65 Thousand USD | 106.89% |
| 2016 Q4 | 607.83 Thousand USD | 482.92% |
| 2016 Q2 | 189.44 Thousand USD | 149.55% |
| 2016 FY | 977.47 Thousand USD | -23.41% |
| 2016 Q3 | 104.27 Thousand USD | -44.96% |
| 2016 Q1 | 75.91 Thousand USD | -83.62% |
| 2015 FY | 1.27 Million USD | 16.81% |
| 2015 Q4 | 463.53 Thousand USD | 77.43% |
| 2015 Q3 | 261.24 Thousand USD | -27.88% |
| 2015 Q2 | 362.24 Thousand USD | 91.47% |
| 2015 Q1 | 189.19 Thousand USD | -63.37% |
| 2014 Q1 | 104.32 Thousand USD | -68.58% |
| 2014 Q2 | 269.95 Thousand USD | 158.77% |
| 2014 Q3 | 201.82 Thousand USD | -25.24% |
| 2014 Q4 | 516.42 Thousand USD | 155.88% |
| 2014 FY | 1.09 Million USD | 215.87% |
| 2013 Q1 | -52.62 Thousand USD | -160.94% |
| 2013 Q2 | 51.17 Thousand USD | 197.24% |
| 2013 Q3 | 15.33 Thousand USD | -70.03% |
| 2013 Q4 | 331.99 Thousand USD | 2064.55% |
| 2013 FY | 345.88 Thousand USD | 125.79% |
| 2012 Q4 | 86.34 Thousand USD | 132.78% |
| 2012 FY | -1.34 Million USD | 2.15% |
| 2012 Q2 | -716.27 Thousand USD | -60.0% |
| 2012 Q1 | -447.68 Thousand USD | -79.18% |
| 2012 Q3 | -263.4 Thousand USD | 63.23% |
| 2011 FY | -1.37 Million USD | 8.76% |
| 2011 Q4 | -249.85 Thousand USD | -17.03% |
| 2011 Q2 | -287.74 Thousand USD | 53.54% |
| 2011 Q1 | -619.35 Thousand USD | -20.61% |
| 2011 Q3 | -213.48 Thousand USD | 25.81% |
| 2010 Q4 | -513.52 Thousand USD | -147.19% |
| 2010 FY | -1.5 Million USD | -14.78% |
| 2010 Q2 | -301.6 Thousand USD | 37.06% |
| 2010 Q3 | -207.74 Thousand USD | 31.12% |
| 2010 Q1 | -479.17 Thousand USD | 3.75% |
| 2009 Q2 | -432.92 Thousand USD | -2135.2% |
| 2009 FY | -1.3 Million USD | -280.26% |
| 2009 Q4 | -497.87 Thousand USD | -584.48% |
| 2009 Q3 | -72.73 Thousand USD | 83.2% |
| 2009 Q1 | -19.36 Thousand USD | 78.44% |
| 2008 FY | -344.13 Thousand USD | -57.1% |
| 2008 Q2 | -229.39 Thousand USD | -1050.42% |
| 2008 Q1 | -19.94 Thousand USD | -239.84% |
| 2008 Q3 | -48.98 Thousand USD | 78.65% |
| 2008 Q4 | -89.84 Thousand USD | -83.42% |
| 2007 FY | -219.05 Thousand USD | 0.0% |
| 2007 Q2 | -192.51 Thousand USD | 0.0% |
| 2007 Q3 | -15.62 Thousand USD | 91.88% |
| 2007 Q4 | 14.26 Thousand USD | 191.28% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 201.351% |
| IR-Med Inc. | -4.91 Million USD | 105.661% |
| Polarean Imaging plc | -12.55 Million USD | 102.214% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 36.556% |
| Avitar, Inc. | 2.73 Million USD | 89.827% |
| AVITA Medical, Inc. | -40.4 Million USD | 100.688% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | 139.544% |
| Össur hf. | 87.46 Million USD | 99.682% |
| Zecotek Photonics Inc. | -3.65 Million USD | 107.602% |
| QHSLab, Inc. | -240.15 Thousand USD | 215.756% |
| Wellstar International, Inc. | -1.79 Million USD | 115.49% |
| Össur hf. | 87.46 Million USD | 99.682% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 86.641% |
| Escalon Medical Corp. | -104.47 Thousand USD | 366.087% |
| Aurora Spine Corporation | -446.19 Thousand USD | 162.304% |
| BrainsWay Ltd. | -4.92 Million USD | 105.642% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | -9.45 Million USD | 102.939% |
| Vivos Inc. | -2.79 Million USD | 109.953% |
| MicroPort Scientific Corporation | -516.16 Million USD | 100.054% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | 216.236% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 115.691% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 173.368% |
| Nanomix Corporation | -8.43 Million USD | 103.295% |
| Theraclion SA | -3.48 Million USD | 107.986% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | 139.319% |
| Positron Corporation | -1.36 Million USD | 120.43% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | 113.463% |
| Lombard Medical, Inc. | -29.33 Million USD | 100.948% |
| ALR Technologies Inc. | -2.94 Million USD | 109.435% |
| Stratec SE | 25.26 Million USD | 98.9% |
| Vycor Medical, Inc. | 40.19 Thousand USD | -591.69% |
| Heart Tronics, Inc. | 14.46 Million USD | 98.077% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | 330.653% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 101.341% |
| SANUWAVE Health, Inc. | -540 Thousand USD | 151.481% |
| VMS Rehab Systems, Inc. | -68.66 USD | 404989.31% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 108.042% |
| Ingen Technologies, Inc. | -1.61 Million USD | 117.228% |
| Odyssey Group International, Inc. | 14.26 Million USD | 98.051% |
| United American Healthcare Corporation | -67 Thousand USD | 514.921% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | 168.223% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | 143.801% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | 146.216% |
| Urologix, Inc. | -6.93 Million USD | 104.012% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | 122.005% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 104.437% |
| SS Innovations International, Inc. | -20.66 Million USD | 101.345% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | 220.742% |
| Smith & Nephew plc | 425 Million USD | 99.935% |
| NIOX Group Plc | 4.6 Million USD | 93.957% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 27.571% |
| Broncus Holding Corporation | -33.22 Million USD | 100.837% |
| Brain Scientific Inc. | -9.6 Million USD | 102.893% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 102.925% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | 557.993% |